Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (6): 1214-1218. doi: 10.19723/j.issn.1671-167X.2022.06.026
Previous Articles Next Articles
Xiao-yan XING1,Jun-xiao ZHANG2,Feng-yun-zhi ZHU1,Yi-fan WANG1,Xin-yao ZHOU3,Yu-hui LI1,*()
CLC Number:
1 |
Bohan A , Peter JB . Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975, 292 (7): 344- 347.
doi: 10.1056/NEJM197502132920706 |
2 |
Lundberg IE , Tjarnlund A , Bottai M , et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups[J]. Ann Rheum Dis, 2017, 76 (12): 1955- 1964.
doi: 10.1136/annrheumdis-2017-211468 |
3 |
Henter JI , Horne A , Arico M , et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48 (2): 124- 131.
doi: 10.1002/pbc.21039 |
4 |
Lerkvaleekul B , Vilaiyuk S . Macrophage activation syndrome: Early diagnosis is key[J]. Open Access Rheumatol, 2018, 10, 117- 128.
doi: 10.2147/OARRR.S151013 |
5 |
Kumakura S , Murakawa Y . Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults[J]. Arthritis Rheumatol, 2014, 66 (8): 2297- 2307.
doi: 10.1002/art.38672 |
6 |
Liang J , Xu D , Sun C , et al. Hemophagocytic lymphohistiocytosis: Prevalence, risk factors, outcome, and outcome-related factors in adult idiopathic inflammatory myopathies[J]. J Rheumatol, 2020, 47 (10): 1532- 1540.
doi: 10.3899/jrheum.190542 |
7 |
Minoia F , Davi S , Horne A , et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A multinational, multicenter study of 362 patients[J]. Arthritis Rheumatol, 2014, 66 (11): 3160- 3169.
doi: 10.1002/art.38802 |
8 |
Tang S , Li S , Zheng S , et al. Understanding of cytokines and targeted therapy in macrophage activation syndrome[J]. Semin Arthritis Rheum, 2021, 51 (1): 198- 210.
doi: 10.1016/j.semarthrit.2020.12.007 |
9 |
Kostik MM , Dubko MF , Masalova VV , et al. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis[J]. Semin Arthritis Rheum, 2015, 44 (4): 417- 422.
doi: 10.1016/j.semarthrit.2014.09.004 |
10 |
Fardet L , Galicier L , Lambotte O , et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome[J]. Arthritis Rheumatol, 2014, 66 (9): 2613- 2620.
doi: 10.1002/art.38690 |
11 |
Schulert GS . The storm beneath the storm: MAS-HLH in inflammatory myopathies[J]. J Rheumatol, 2020, 47 (10): 1461- 1463.
doi: 10.3899/jrheum.191274 |
12 |
Gono T , Kawaguchi Y , Ozeki E , et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis[J]. Mod Rheumatol, 2011, 21 (2): 223- 227.
doi: 10.3109/s10165-010-0371-x |
13 |
La Rosee P , Horne A , Hines M , et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults[J]. Blood, 2019, 133 (23): 2465- 2477.
doi: 10.1182/blood.2018894618 |
14 |
Canna SW , Girard C , Malle L , et al. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition[J]. J Allergy Clin Immunol, 2017, 139 (5): 1698- 1701.
doi: 10.1016/j.jaci.2016.10.022 |
15 |
Gabr JB , Liu E , Mian S , et al. Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: Case report and review of the literature[J]. Ann Transl Med, 2020, 8 (14): 887.
doi: 10.21037/atm-20-3127 |
16 |
Ahmed A , Merrill SA , Alsawah F , et al. Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: An open-label, single-centre, pilot trial[J]. Lancet Haematol, 2019, 6 (12): e630- e637.
doi: 10.1016/S2352-3026(19)30156-5 |
17 |
Verweyen E , Holzinger D , Weinhage T , et al. Synergistic signaling of TLR and IFNalpha/beta facilitates escape of IL-18 expression from endotoxin tolerance[J]. Am J Respir Crit Care Med, 2020, 201 (5): 526- 539.
doi: 10.1164/rccm.201903-0659OC |
18 | Wu J, Sun L, Tang X, et al. Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis associated refractory macrophage activation syndrome[J]. Mod Rheumatol, 2021[2022-08-01]. https://doi.org/10.1093/mr/roab119. |
19 |
Fujita Y , Fukui S , Suzuki T , et al. Anti-MDA5 antibody-positive dermatomyositis complicated by autoimmune-associated hemophagocytic syndrome that was successfully treated with immunosuppressive therapy and plasmapheresis[J]. Intern Med, 2018, 57 (23): 3473- 3478.
doi: 10.2169/internalmedicine.1121-18 |
20 |
Kaieda S , Yoshida N , Yamashita F , et al. Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis[J]. Mod Rheumatol, 2015, 25 (6): 962- 966.
doi: 10.3109/14397595.2013.844402 |
21 |
Komiya Y , Saito T , Mizoguchi F , et al. Hemophagocytic syndrome complicated with dermatomyositis controlled successfully with infliximab and conventional therapies[J]. Intern Med, 2017, 56 (23): 3237- 3241.
doi: 10.2169/internalmedicine.7966-16 |
22 |
Sasaki H , Kohsaka H . Current diagnosis and treatment of polymyositis and dermatomyositis[J]. Mod Rheumatol, 2018, 28 (6): 913- 921.
doi: 10.1080/14397595.2018.1467257 |
23 |
Gavand PE , Serio I , Arnaud L , et al. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients[J]. Autoimmun Rev, 2017, 16 (7): 743- 749.
doi: 10.1016/j.autrev.2017.05.010 |
[1] | Xiao-juan ZHU,Hong ZHANG,Shuang ZHANG,Dong LI,Xin LI,Ling XU,Ting LI. Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 243-253. |
[2] | Yu-mei LAI,Zhong-wu LI,Huan LI,Yan WU,Yun-fei SHI,Li-xin ZHOU,Yu-tong LOU,Chuan-liang CUI. Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 262-269. |
[3] | Qi SHEN,Yi-xiao LIU,Qun HE. Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 276-282. |
[4] | Fang CAO,Ming ZHONG,Cong-rong LIU. Uterine POLE mutant endometrioid carcinoma combined with human papilloma virus-associated cervical adenocarcinoma: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 370-374. |
[5] | Yi-lin YE,Heng LIU,Li-ping PAN,Wei-bing CHAI. Periprosthetic gout flare after total knee arthroplasty: A misdiagnostic case report [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 362-365. |
[6] | Qian SU,Xin PENG,Chuan-xiang ZHOU,Guang-yan YU. Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 13-21. |
[7] | Quan ZHANG,Hai-feng SONG,Bing-lei MA,Zhe-nan ZHANG,Chao-hui ZHOU,Ao-lin LI,Jun LIU,Lei LIANG,Shi-yu ZHU,Qian ZHANG. Pre-operative prognostic nutritional index as a predictive factor for prognosis in non-metastatic renal cell carcinoma treated with surgery [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 149-155. |
[8] | Le-qing CAO,Jing-rui ZHOU,Yu-hong CHEN,Huan CHEN,Wei HAN,Yao CHEN,Yuan-yuan ZHANG,Chen-hua YAN,Yi-fei CHENG,Xiao-dong MO,Hai-xia FU,Ting-ting HAN,Meng LV,Jun KONG,Yu-qian SUN,Yu WANG,Lan-ping XU,Xiao-hui ZHANG,Xiao-jun HUANG. Relationship between treatment and prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1013-1020. |
[9] | Min QIU,Yan-yan LIAN,Min LU,Bin-shuai WANG,Xiao-jun TIAN,Jian LU,Cheng LIU,Shu-dong ZHANG,Min JIANG,Lu-lin MA. Treatment and prognosis of multiple primary malignant neoplasms complicated with renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 680-685. |
[10] | Er-shu BO,Peng HONG,Yu ZHANG,Shao-hui DENG,Li-yuan GE,Min LU,Nan LI,Lu-lin MA,Shu-dong ZHANG. Clinicopathological features and prognostic analysis of papillary renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 615-620. |
[11] | Zhi-yu KANG,Lei-lei WANG,Yong-zheng HAN,Xiang-yang GUO. Anesthesia management of athletes' operation in Beijing Olympic Winter Games [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 770-773. |
[12] | Yu-han DENG,Yong JIANG,Zi-yao WANG,Shuang LIU,Yu-xin WANG,Bao-hua LIU. Long short-term memory and Logistic regression for mortality risk prediction of intensive care unit patients with stroke [J]. Journal of Peking University (Health Sciences), 2022, 54(3): 458-467. |
[13] | LAN Lin,HE Yang,AN Jin-gang,ZHANG Yi. Relationship between prognosis and different surgical treatments of zygomatic defects: A retrospective study [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 356-362. |
[14] | ZHANG Pu-li,YANG Hong-xia,ZHANG Li-ning,GE Yong-peng,PENG Qing-lin,WANG Guo-chun,LU Xin. Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1055-1060. |
[15] | WANG Fei,ZHU Xiang,HE Bei,ZHU Hong,SHEN Ning. Spontaneous remission of follicular bronchiolitis with nonspecific interstitial pneumonia: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1196-1200. |